Meidi U. Puteri
Depokpasir, JB 16424, Indonesia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 17 publications
PCSK9 as a Potential Regulator of Endothelial Dysfunction: Mechanistic Insights and Future Directions.
Journal: International journal of molecular sciences
Published: June 12, 2026
Role of PCSK9 in breast cancer: a systematic review of its mechanistic pathways and clinical relevance.
Journal: Frontiers in pharmacology
Published: April 07, 2026
PCSK9-Mediated Inflammation in Foam Cell Formation and Exploring the Biologically Active Compounds Derived From Natural Resources.
Journal: Advances in pharmacological and pharmaceutical sciences
Published: December 31, 2025
Metabolic Drivers of Alzheimer's Disease: Integrating brain Hypometabolism, insulin Resistance, and systemic dysregulation.
Journal: Frontiers in neuroendocrinology
Published: December 25, 2025
PCSK9 in Cancer: Biological Mechanisms and Implications for Therapeutic Resistance.
Journal: Biomolecules
Published: November 24, 2025
The Roles of PCSK9 in Alzheimer's Disease: A Systematic Review of Clinical, Genetic, and Preclinical Evidence.
Journal: Life (Basel, Switzerland)
Published: October 20, 2025
Ultrasonic-assisted extraction (UAE) of Javanese turmeric rhizomes using natural deep eutectic solvents (NADES): Screening, optimization, and in vitro cytotoxicity evaluation.
Journal: Ultrasonics sonochemistry
Published: November 29, 2024
Antiplatelet Effects of a Combination of Sappan Wood (Caesalpinia sappan L.) and Red Ginger (Zingiber officinale var. Rubrum) Extracts in a High-Fat Diet-Induced Rat Model.
Journal: Advances in pharmacological and pharmaceutical sciences
Published: June 05, 2024
Platelet Glycoprotein-Ib (GPIb) May Serve as a Bridge between Type 2 Diabetes Mellitus (T2DM) and Atherosclerosis, Making It a Potential Target for Antiplatelet Agents in T2DM Patients.
Journal: Life (Basel, Switzerland)
Published: May 29, 2023
Brazilin from Caesalpinia sappan L. as a Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Inhibitor: Pharmacophore-Based Virtual Screening, In Silico Molecular Docking, and In Vitro Studies.
Journal: Advances in pharmacological and pharmaceutical sciences
Published: May 17, 2023
Recent Update on PCSK9 and Platelet Activation Experimental Research Methods: In Vitro and In Vivo Studies.
Journal: Journal of cardiovascular development and disease
Published: July 16, 2022
Last Updated: 09/26/2026